calpeptin has been researched along with Disease Models, Animal in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 11 (68.75) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
de la Fuente, S; Garcera, A; Hidalgo, I; Romero-Guevara, R; Sansa, A; Soler, RM; Vivancos, N | 1 |
Greer, PA; Huang, H; Ma, WL; Shi, HZ; Song, LJ; Su, Y; Xiang, F; Xin, JB; Xiong, L; Xu, JJ; Yang, J; Ye, H; Yu, F | 1 |
Bakker-van Bebber, M; Nijenhuis, T; Sonneveld, R; van der Vlag, J; Verheijden, KAT; Wetzels, JFM | 1 |
Cai, L; Zhou, YD | 1 |
Bahr, BA; Bojcevski, J; Diem, R; Fairless, R; Hoffmann, DB; Müller, A; Naidoo, V; Stadelmann, C; Williams, SK | 1 |
Cheng, X; Lin, Y; Mao, X; Zhang, J; Zhou, T | 1 |
Chen, X; Guo, H; Huang, J; Ma, S; Shi, L; Zhu, X | 1 |
Banik, NL; Becker, HC; Knaryan, VH; Mulholland, PJ; Patel, KS; Samantaray, S | 1 |
Fujita, H; Manabe, T; Miyasaka, Y; Mizumoto, K; Nabae, T; Nakamura, M; Ohtsuka, T; Ohuchida, K; Okumura, T; Shimamoto, M; Torata, N; Yoshida, M; Zheng, B | 1 |
Cai, PC; Fang, J; Greer, PA; Li, FZ; Lin, YX; Liu, F; Ma, WL; Mu, Q; Rao, SS; Shi, HZ; Song, LJ; Su, Y; Xia, Y; Yang, J; Ye, H; Zeng, Y; Zhang, Q; Zhou, LL | 1 |
Balasubramanian, S; Jeffords, LB; Kuppuswamy, D; Mani, SK; Mukherjee, R; Rivers, WT; Spinale, FG; Zavadzkas, JA; Zile, MR | 1 |
Banik, NL; Das, A; Guyton, MK; Ray, SK; Rohrer, B; Smith, AW | 1 |
Banik, NL; Das, A; Guyton, MK; Matzelle, DD; McDowell, ML; Ray, SK; Smith, A; Wallace, G | 1 |
Ali, SF; Banik, NL; Ray, SK; Samantaray, S | 1 |
Balasubramanian, S; Banik, N; Chellaiah, M; Cooper, G; Kuppuswamy, D; Mani, SK; Shiraishi, H; Yamane, K; Zile, MR | 1 |
16 other study(ies) available for calpeptin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
Topics: Animals; Calcium-Binding Proteins; Calpain; Carrier Proteins; Cell Differentiation; Cell Line; Cell Survival; Cells, Cultured; Dipeptides; Disease Models, Animal; Fibroblasts; Humans; Induced Pluripotent Stem Cells; Mice; Mice, Mutant Strains; Microfilament Proteins; Microtubule-Associated Proteins; Motor Neurons; Muscular Atrophy, Spinal; Proteolysis; Spinal Cord; Survival of Motor Neuron 1 Protein | 2020 |
Inhibition of angiotensin II and calpain attenuates pleural fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bleomycin; Calpain; Carbon; Cell Line; Collagen Type I; Dipeptides; Disease Models, Animal; Fibrosis; Humans; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pleural Diseases | 2018 |
The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Topics: Analysis of Variance; Animals; Blotting, Western; Calcineurin; Calcium; Calpain; Case-Control Studies; Cells, Cultured; Dipeptides; Disease Models, Animal; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Humans; Male; Podocytes; Proteinuria; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reference Values; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel; Up-Regulation | 2018 |
Calpeptin Reduces Neurobehavioral Deficits and Neuronal Apoptosis Following Subarachnoid Hemorrhage in Rats.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cerebral Cortex; Dipeptides; Disease Models, Animal; Male; Neurons; Neuroprotective Agents; Random Allocation; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2019 |
Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis.
Topics: Amyloid beta-Protein Precursor; Animals; Calcium; Calpain; Chlorides; Dipeptides; Disease Models, Animal; Ectodysplasins; Encephalomyelitis, Autoimmune, Experimental; Female; Magnetic Resonance Imaging; Manganese Compounds; Myelin-Oligodendrocyte Glycoprotein; Nerve Degeneration; Neuroprostanes; Optic Nerve; Optic Neuritis; Rats; Retina; Retinal Ganglion Cells; Time Factors | 2013 |
IL-17A contributes to brain ischemia reperfusion injury through calpain-TRPC6 pathway in mice.
Topics: Animals; Brain; Brain Ischemia; Calpain; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Infarction, Middle Cerebral Artery; Interleukin-17; Male; Mice, Inbred C57BL; Mice, Knockout; Proteolysis; Recombinant Proteins; Reperfusion Injury; Time Factors; TRPC Cation Channels; TRPC6 Cation Channel | 2014 |
[The effect of calpeptin on injury and atrophy of diaphragm under mechanical ventilation in rats].
Topics: Animals; Atrophy; Calpain; Diaphragm; Dipeptides; Disease Models, Animal; Male; Myosin Heavy Chains; Rats; Rats, Sprague-Dawley; Respiration, Artificial | 2014 |
Chronic intermittent ethanol induced axon and myelin degeneration is attenuated by calpain inhibition.
Topics: Administration, Inhalation; Alcoholism; Animals; Axons; Brain; Calpain; Central Nervous System Depressants; Dipeptides; Disease Models, Animal; Ethanol; Glycoproteins; Male; Mice, Inbred C57BL; Myelin Sheath; Nerve Degeneration; Neuroprotective Agents; Spinal Cord; Substance Withdrawal Syndrome | 2015 |
Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.
Topics: Animals; Calpain; Cell Communication; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dipeptides; Disease Models, Animal; Gene Expression; Humans; Mice; Pancreatic Neoplasms; Pancreatic Stellate Cells; RNA, Messenger; Stromal Cells; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma.
Topics: Airway Remodeling; Animals; Asthma; Calpain; Cell Proliferation; Collagen Type I; Cytokines; Dipeptides; Disease Models, Animal; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Knockout; Muscle, Smooth; Myocytes, Smooth Muscle; Phosphorylation; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Signal Transduction | 2017 |
Calpain inhibition preserves myocardial structure and function following myocardial infarction.
Topics: Animals; Apoptosis; Calpain; Cardiotonic Agents; Caspase 3; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Enzyme Activation; Injections, Intravenous; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardium; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis.
Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Calpain; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Gene Expression Regulation; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Optic Neuritis; Rats; Rats, Inbred Lew; Retinal Ganglion Cells; RNA; Treatment Outcome | 2011 |
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Topics: Animals; Apoptosis; Aquaporin 4; Calcium; Calpain; Cyclooxygenase 2; Cytokines; Dipeptides; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Glycoproteins; Male; Molecular Weight; Myelin Basic Protein; NF-kappa B; Nitric Oxide Synthase Type II; Optic Nerve; Optic Neuritis; Rats; Rats, Inbred Lew; Signal Transduction | 2013 |
Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism.
Topics: Animals; Apoptosis; Calpain; Cell Culture Techniques; Dipeptides; Disease Models, Animal; DNA Fragmentation; Humans; In Situ Nick-End Labeling; Motor Neurons; Parkinsonian Disorders; Rats | 2006 |
In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Calpain; Cardiomegaly; Caspase 3; Caspase Inhibitors; Cats; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Enzyme Activation; Gelsolin; Heart Failure; Histones; In Situ Nick-End Labeling; Injections, Intravenous; Ligation; Male; Myocytes, Cardiac; Phosphorylation; Pulmonary Artery; Time Factors | 2008 |